Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.242 USD | +2.60% | +18.24% | +125.73% |
Evolution of the average Target Price on Xilio Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Xilio Therapeutics, Inc.
Morgan Stanley | |
Chardan Research | |
Raymond James | |
HC Wainwright | |
Cowen | |
Guggenheim |
EPS Revisions
- Stock Market
- Equities
- XLO Stock
- Consensus Xilio Therapeutics, Inc.